Company Suzhou Fushilai Pharmaceutical Co., Ltd.

Equities

301258

CNE1000058W2

Pharmaceuticals

End-of-day quote Shenzhen S.E. 06:00:00 2024-05-09 pm EDT 5-day change 1st Jan Change
35.68 CNY -8.21% Intraday chart for Suzhou Fushilai Pharmaceutical Co., Ltd. +26.79% +10.53%

Business Summary

Suzhou Fushilai Pharmaceutical Co Ltd is a China-based company mainly engaged in the production and sales of pharmaceuticals. The Company is mainly engaged in the research and development, production and sales of pharmaceutical intermediates, active pharmaceutical ingredients (APIs) and raw materials for health care products. The Company's main products include three series of lipoic acid series, phosphatidylcholine series and carnosine series. The Company mainly conducts its business in domestic and overseas markets such as Europe, America, Japan and South Korea, India and South America.

Number of employees: 544

Sales per Business

CNY in Million2022Weight2023Weight Delta
Lipoic Acid Series
76.6 %
454 79.9 % 375 76.6 % -17.38%
Carnosine Series
12.2 %
53 9.3 % 60 12.2 % +13.56%
Phosphatidylcholine Series
8.5 %
40 7.1 % 42 8.5 % +2.91%
Irecoxib
1.4 %
2 0.4 % 7 1.4 % +231.99%
Other Business
1.3 %
19 3.4 % 6 1.3 % -67.86%

Sales per region

CNY in Million2022Weight2023Weight Delta
Abroad
62.9 %
371 65.2 % 308 62.9 % -16.93%
China
37.1 %
198 34.8 % 181 37.1 % -8.19%

Managers

Managers TitleAgeSince
Chief Executive Officer 54 00-10-31
Chairman 49 10-02-28
Director of Finance/CFO 38 14-02-28
Director/Board Member 44 99-12-31

Members of the board

Members of the board TitleAgeSince
Director/Board Member 38 19-09-11
Director/Board Member 60 22-09-08
Director/Board Member 61 22-09-08
Chief Executive Officer 54 00-10-31
Director of Finance/CFO 38 14-02-28
Director/Board Member 44 99-12-31
Chairman 49 10-02-28

Shareholders

NameEquities%Valuation
Galaxy Asset Management Co., Ltd.
-
751,850 - 3 M ¥
China Southern Asset Management Co., Ltd.
-
155,900 - 549 618 ¥
Hui'an Fund Management Co. Ltd.
-
60,700 - 213 995 ¥
Gfund Management Co., Ltd.
-
8,400 - 29 614 ¥
Da Cheng Fund Management Co., Ltd.
-
6,037 - 21 283 ¥
Bosera Asset Management Co., Ltd.
-
4,623 - 16 298 ¥
Lion Fund Management Co., Ltd.
-
3,371 - 11 884 ¥
Fortune & Royal Asset Management Co., Ltd.
-
2,206 - 7 777 ¥
GF Fund Management Co., Ltd.
-
2,065 - 7 280 ¥
Essence Fund Co., Ltd.
-
1,654 - 5 831 ¥

Company contact information

Suzhou Fushilai Pharmaceutical Co., Ltd.

16 Haiwang Road New Materials Industrial Park

215500, Changshu

+

http://www.fuslai.com
address Suzhou Fushilai Pharmaceutical Co., Ltd.(301258)
  1. Stock Market
  2. Equities
  3. 301258 Stock
  4. Company Suzhou Fushilai Pharmaceutical Co., Ltd.
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
SIGN UP NOW